OBJECTIVE: Wider application of CT angiography (CTA) improves the diagnosis of acute pulmonary embolism (PE). It also permits the visualisation of saddle embolism (SE), namely thrombi, which are located at the bifurcation of the main pulmonary artery. The aim of this study was to assess the prevalence of SE and whether SE predicts a complicated clinical course in patients with non-high-risk PE. METHODS: In total, 297 consecutive patients with non-high-risk PE confirmed using CTA in the emergency department were studied. The presence of SE and its ability to predict the occurrence of major adverse events (MAEs) within 1 month were determined. RESULTS: Of the 297 patients, 27 (9.1%) had an SE. The overall mortality at 1 month was 12.5%; no significant difference was observed between the SE and non-SE groups (18.5% vs 11.9%, p=0.32). However, patients with SE were more likely to receive thrombolytic therapy (29.6% vs 8.1%, p<0.01) and had significantly more MAEs (59.3% vs 25.6%, p<0.01). CONCLUSION: At the time of diagnosis, SE, as determined using CTA, is associated with the development of MAE within 1 month. It may be a simple method for risk stratification of patients with non-high-risk PE. ADVANCES IN KNOWLEDGE: The prognosis of patients with SE, especially those who are haemodynamically stable, is unclear. This study shows that patients with SE, determined with CTA, is associated with the development of MAE.
OBJECTIVE: Wider application of CT angiography (CTA) improves the diagnosis of acute pulmonary embolism (PE). It also permits the visualisation of saddle embolism (SE), namely thrombi, which are located at the bifurcation of the main pulmonary artery. The aim of this study was to assess the prevalence of SE and whether SE predicts a complicated clinical course in patients with non-high-risk PE. METHODS: In total, 297 consecutive patients with non-high-risk PE confirmed using CTA in the emergency department were studied. The presence of SE and its ability to predict the occurrence of major adverse events (MAEs) within 1 month were determined. RESULTS: Of the 297 patients, 27 (9.1%) had an SE. The overall mortality at 1 month was 12.5%; no significant difference was observed between the SE and non-SE groups (18.5% vs 11.9%, p=0.32). However, patients with SE were more likely to receive thrombolytic therapy (29.6% vs 8.1%, p<0.01) and had significantly more MAEs (59.3% vs 25.6%, p<0.01). CONCLUSION: At the time of diagnosis, SE, as determined using CTA, is associated with the development of MAE within 1 month. It may be a simple method for risk stratification of patients with non-high-risk PE. ADVANCES IN KNOWLEDGE: The prognosis of patients with SE, especially those who are haemodynamically stable, is unclear. This study shows that patients with SE, determined with CTA, is associated with the development of MAE.
Authors: P Pruszczyk; R Pacho; M Ciurzynski; M Kurzyna; B Burakowska; W Tomkowski; A Bochowicz; A Torbicki Journal: Heart Date: 2003-03 Impact factor: 5.994
Authors: Jay H Ryu; Patricia A Pellikka; David A Froehling; Steve G Peters; Gregory L Aughenbaugh Journal: Respir Med Date: 2007-01-24 Impact factor: 3.415
Authors: Alejandro Sardi; Jill Gluskin; Adam Guttentag; Morris N Kotler; Leonard E Braitman; Michael Lippmann Journal: Crit Care Med Date: 2011-11 Impact factor: 7.598
Authors: Rutger W van der Meer; Peter M T Pattynama; Marco J L van Strijen; Annette A van den Berg-Huijsmans; Ieneke J C Hartmann; Hein Putter; Albert de Roos; Menno V Huisman Journal: Radiology Date: 2005-04-21 Impact factor: 11.105
Authors: U Joseph Schoepf; Nils Kucher; Florian Kipfmueller; Rene Quiroz; Philip Costello; Samuel Z Goldhaber Journal: Circulation Date: 2004-11-08 Impact factor: 29.690
Authors: David R Vinson; Carrieann E Drenten; Jie Huang; J Eileen Morley; Megan L Anderson; Mary E Reed; Daniel K Nishijima; Vincent Liu Journal: Ann Am Thorac Soc Date: 2015-05
Authors: Kevin Solverson; Christopher Humphreys; Zhiying Liang; Graeme Prosperi-Porta; James E Andruchow; Paul Boiteau; Andre Ferland; Eric Herget; Doug Helmersen; Jason Weatherald Journal: ERJ Open Res Date: 2021-04-19